Geron Corp (GERN)
3.55
+0.08
(+2.31%)
USD |
NASDAQ |
May 31, 16:00
3.545
0.00 (0.00%)
After-Hours: 20:00
Geron Revenue (Annual): 0.237M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.237M |
| December 31, 2022 | 0.596M |
| December 31, 2021 | 1.393M |
| December 31, 2020 | 0.253M |
| December 31, 2019 | 0.46M |
| December 31, 2018 | 1.066M |
| December 31, 2017 | 1.065M |
| December 31, 2016 | 6.162M |
| December 31, 2015 | 36.37M |
| December 31, 2014 | 1.153M |
| December 31, 2013 | 1.283M |
| December 31, 2012 | 2.709M |
| December 31, 2011 | 2.438M |
| December 31, 2010 | 3.563M |
| Date | Value |
|---|---|
| December 31, 2009 | 1.726M |
| December 31, 2008 | 2.803M |
| December 31, 2007 | 7.622M |
| December 31, 2006 | 3.277M |
| December 31, 2005 | 0.29M |
| December 31, 2004 | |
| December 31, 2003 | 0.072M |
| December 31, 2002 | 1.248M |
| December 31, 2001 | 3.62M |
| December 31, 2000 | 6.609M |
| December 31, 1999 | 5.40M |
| December 31, 1998 | 6.80M |
| December 31, 1997 | 7.30M |
| December 31, 1996 | 5.30M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
0.237M
Minimum
2023
1.393M
Maximum
2021
0.5878M
Average
0.46M
Median
2019
Revenue (Annual) Benchmarks
| Madrigal Pharmaceuticals Inc | -- |
| SELLAS Life Sciences Group Inc | -- |
| Johnson & Johnson | 85.16B |
| Pfizer Inc | 58.50B |
| Immuneering Corp | -- |